Literature DB >> 26279720

Emphysematous pyelonephritis: Our experience in managing these cases.

Fatih Uruc1, Ozgur Haki Yuksel1, Aytac Sahin1, Ahmet Urkmez1, Caglar Yildirim1, Ayhan Verit1.   

Abstract

INTRODUCTION: Emphysematous pyelonephritis (EPN) is a rare acute necrotising infection of renal parenchyma. We discuss clinical details and treatment strategies of 8 patients with EPN followed at our clinic.
METHODS: We retrospectively reviewed the clinical, laboratory, radiological findings and treatment modalities of 8 patients with EPN followed at our urology clinic between 2012 and 2015.
RESULTS: The mean patient age (female: 5; male: 3) was 62 (range: 51-82) years. Based on computed tomographic findings, EPN was classified as class 1 (n = 3), class 2 (n = 3) and class 3a (n = 2). All patients had fever, flank pain, nausea, and vomiting. Five patients had type 2 diabetes mellitus and 3 diabetic patients also had renal stones. Escherichia coli (n = 6), Klebsiella species (n = 1), and Proteus species (n = 1) were grown in urine cultures. All patients had unilateral involvement. Increased white blood cell counts, sedimentation rate, and C-reactive protein levels were detected in all cases. In addition to medical treatment, 2 patients underwent a nephrostomy catheter placement and another 2 patients underwent nephrectomy upon deterioration of her general health state. After achieving clinical stabilization with medical treatment, 1 patient underwent endoscopic ureteral stone treatment. The remaining 3 cases were treated only with antibiotherapy. All patients were discharged with clinical cure.
CONCLUSION: Mortality rates of EPN are gradually decreasing. Preservation of renal reserve is possible due to early diagnosis, appropriate antibiotherapy, and drainage.

Entities:  

Year:  2015        PMID: 26279720      PMCID: PMC4514496          DOI: 10.5489/cuaj.2828

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  20 in total

1.  Emphysematous pyelonephritis.

Authors:  E H SCHULTZ; E H KLORFEIN
Journal:  J Urol       Date:  1962-06       Impact factor: 7.450

2.  Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome.

Authors:  Y L Wan; T Y Lee; M J Bullard; C C Tsai
Journal:  Radiology       Date:  1996-02       Impact factor: 11.105

Review 3.  Emphysematous pyelonephritis.

Authors:  J Michaeli; P Mogle; S Perlberg; S Heiman; M Caine
Journal:  J Urol       Date:  1984-02       Impact factor: 7.450

4.  Bilateral emphysematous pyelonephritis caused by Candida infection.

Authors:  T S Hildebrand; L Nibbe; U Frei; R Schindler
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

5.  Emphysematous pyelonephritis in a renal allograft: successful treatment with percutaneous drainage and nephrostomy.

Authors:  Y T Cheng; H P Wang; H H Hsieh
Journal:  Clin Transplant       Date:  2001-10       Impact factor: 2.863

6.  Emphysematous pyelonephritis: a 15-year experience with 20 cases.

Authors:  A A Shokeir; M El-Azab; T Mohsen; T El-Diasty
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

7.  Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis.

Authors:  Ambar Khaira; Ankur Gupta; Devendra S Rana; Ashwini Gupta; Anil Bhalla; Dinesh Khullar
Journal:  Int Urol Nephrol       Date:  2009-04-30       Impact factor: 2.370

8.  Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis.

Authors:  Matthew E Falagas; Vangelis G Alexiou; Konstantina P Giannopoulou; Ilias I Siempos
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

Review 9.  Acute bilateral emphysematous pyelonephritis successfully managed by medical therapy alone: a case report and review of the literature.

Authors:  Guillermo Flores; Haiko Nellen; Francisco Magaña; Juan Calleja
Journal:  BMC Nephrol       Date:  2002-06-03       Impact factor: 2.388

10.  Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis.

Authors:  Yu-Chuan Lu; Bing-Juin Chiang; Yuan-Hung Pong; Kuo-How Huang; Po-Ren Hsueh; Chao-Yuan Huang; Yeong-Shiau Pu
Journal:  BMC Infect Dis       Date:  2014-07-29       Impact factor: 3.090

View more
  7 in total

1.  Deriving a management algorithm for emphysematous pyelonephritis: Can we rely on minimally invasive strategies or should we be opting for earlier nephrectomy?

Authors:  Eve Boakes; Deepak Batura
Journal:  Int Urol Nephrol       Date:  2017-09-20       Impact factor: 2.370

2.  Outcome of conservative and minimally invasive management in emphysematous pyelonephritis.

Authors:  Soumish Sengupta; Supriyo Basu
Journal:  Urol Ann       Date:  2021-05-28

3.  Emphysematous pyelonephritis: Six case reports and review of literature.

Authors:  Li-Ping Ma; Ning Zhou; Yan Fu; Yan Liu; Cong Wang; Bin Zhao
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

4.  The Presence of Venous Gas Does Not Affect the Prognosis in Emphysematous Cystitis.

Authors:  Yuki Yoshimatsu; Tomoko Takai; Yasuhisa Abe; Toshimasa Nakagawa
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

5.  Emphysematous Pyelonephritis: A single center review.

Authors:  Albeerdy Mohammad Irfaan; Nadeem Ahmed Shaikh; Anila Jamshaid; Abdul Hafeez Qureshi
Journal:  Pak J Med Sci       Date:  2020-01       Impact factor: 1.088

6.  Successful endoscopic surgery for emphysematous pyelonephritis in a non-diabetic patient with autosomal dominant polycystic kidney disease: A case report.

Authors:  Yi Jiang; Richard Lo; Zhen-Quan Lu; Xiao-Bao Cheng; Lin Xiong; Bing-Feng Luo
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

7.  Clinical profile and successful outcomes of conservative and minimally invasive treatment of emphysematous pyelonephritis.

Authors:  Vilvapathy Senguttuvan Karthikeyan; Chikka Moga Siddaiah Manohar; Ashwin Mallya; Ramaiah Keshavamurthy; Anant Janardhan Kamath
Journal:  Cent European J Urol       Date:  2018-04-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.